AIDS prevention gel fails in African trials


  • World Premium
  • Tuesday, 15 Dec 2009

LONDON (Reuters) - U.S. drug company Endo Pharmaceuticals' gel designed to prevent infection with the AIDS virus was ineffective in trials in Africa, Britain's Medical Research Council (MRC) said on Monday.

The large international trial of vaginal microbicide Pro 2000 in more than 9,000 women in four African countries found no evidence that it reduces the risk of HIV infection.

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights
   

Next In World

'Horrific' destruction, casualties if Russia invades Ukraine -U.S. Premium
Working with U.S., Guatemala detains 10 people in raids on migrant smugglers Premium
Ukraine's president lashes out at too much 'panic' over Russia tensions Premium
Beleaguered Trudeau rival embraces trucker protest despite concerns of violence Premium
Biden administration to deny $130 million in military aid to Egypt -sources Premium
Exclusive-Russia moves blood supplies near Ukraine, adding to U.S. concern, officials say Premium
Russia says 184 staff to stay at embassy in U.S. after expulsion Premium
Tunisia thwarts alleged terrorist attack targeting tourist areas Premium
Some Kazakh protesters feel they were tricked into fuelling clan feud Premium
Indian village mourns family who froze to death on U.S.-Canada border Premium

Others Also Read


Vouchers